STAT3 and neoplasm: Mounting evidence shows that constitutively activated STAT3 contributes to tumour development and progression in most cancers, including breast, prostate, gastric, pancreas, colorectum, cervix, ovary, lung, melanoma and blood cancers.6, 7, 8, 9, 10